Literature DB >> 7044905

Biological determinants of altered pharmacokinetics in the elderly.

D G Shand.   

Abstract

The biological determinants of drug disposition have been clearly identified and methods are available to quantify what effects altering them will have on drug kinetics. The factors include blood flow and intrinsic clearance of the organ of elimination, drug binding in blood and tissues, and, in the case of drugs eliminated by the liver, the oral route of administration. The effects of these various factors on drug elimination depend on the efficiency of the elimination process. At one end of the spectrum, some drug elimination is very efficient as it is largely flow-dependent, while at the other elimination depends largely on intrinsic clearance. The oral route of elimination may be important for drugs which undergo efficient hepatic extraction, when a large "first-pass" effect results. In addition, that fraction of the drug escaping first-pass elimination is largely dependent on intrinsic clearance and not flow. Finally, plasma drug binding may affect both elimination and drug distribution. The way in which these factors can be affected by the aging process will be discussed and illustrated with examples showing how changes in organ blood flow, intrinsic clearance and plasma drug binding can produce pharmacokinetic changes seen in the elderly.

Mesh:

Substances:

Year:  1982        PMID: 7044905     DOI: 10.1159/000212568

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  16 in total

1.  Effects of age and gender on pharmacokinetics of cefepime.

Authors:  R H Barbhaiya; C A Knupp; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.

Authors:  B T Veering; A G Burm; J H Souverijn; J M Serree; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

Review 3.  [Pharmacological peculiarities and problems with older patients].

Authors:  C D Kratz; A Schleppers; T Iber; G Geldner
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

4.  Effect of age and renal function on cefonicid pharmacokinetics.

Authors:  J M Trang; T P Monson; B H Ackerman; F L Underwood; J T Manning; G L Kearns
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults.

Authors:  A Darragh; A J Gordon; H O'Byrne; D Hobbs; E Casey
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Pharmacokinetics of ceftazidime in elderly volunteers.

Authors:  M LeBel; G Barbeau; F Vallee; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

7.  Effect of age and sex on the plasma binding of acidic and basic drugs.

Authors:  R K Verbeeck; J A Cardinal; S M Wallace
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.

Authors:  B R Meyers; M H Mendelson; R G Deeter; E Srulevitch-Chin; M T Sarni; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.

Authors:  F Sörgel; E Abisch; H J Dennler; E Lang
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.

Authors:  J Shah; P Teitelbaum; B Molony; T Gabuzda; I Massey
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.